Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins

Genes and Development

Volumn 10, Issue 23, 1996, Pages 2960-2970

  Hateboer, Guus ^a,b   Kerkhoven, Ron M ^a   Shvarts, Avi ^a   Bernards, René ^a   Beijersbergen, Roderick L ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

cell cycle; E2F; ubiquitin

Indexed keywords

PROTEASOME; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STABILITY;

ADENOVIRIDAE;

EID: 0029797841     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.23.2960     Document Type: Article

References (63)

1. Beijersbergen, R.L. and R. Bernards. 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochem. Biophys. Act 1287: 103-120.
2. Beijersbergen, R.L., R. Kerkhoven, L. Zhu, L. Carlée, P.M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes & Dev. 8: 2680-2690.
3. Beijersbergen, R.L., L. Cariée, R.M. Kerkhoven, and R. Bernards. 1995. Regulation of the retinoblastoma-related p107 by G1 cyclin complexes. Genes & Dev. 9: 1340-1353.
4. Bernards, R., A. Houweling, P.I. Schrier, J.L. Bos, and A.J. Van der Eb. 1982. Characterization of cells transformed by Ad5/ Ad12 hybrid early region 1 plasmids. Virology 120: 422-432.
5. Botz, J., K. Zerfass-Thome, D. Spitkovsky, H. Delius, B. Vogt, M. Eilers, A. Hatzgerogiou, and P. Janssen-Durr. 1996. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell Biol. 16: 3401-3409.
6. Bremner, R., B.L. Cohen, M. Sopta, P.A. Hamel, C.J. Ingles, B.L. Gallic, and R.A. Phillips. 1995. Direct transcriptional repression by pRb and its reversal by specific cyclins. Mol. Cell. Biol. 15: 3256-3265.
7. Chau, V., J.W. Tobias, A. Bachmair, D. Marriott, D.J. Ecker, D.K. Gonda, and A. Varshavsky. 1989. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243: 1576-1583.
8. Chittenden, T., D.M. Livingston, and J.A. DeCaprio. 1993. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol. Cell. Biol. 13: 3975-3983.
9. Clurman, B.E., R.J. Sheaff, K. Thress, M. Groudine, and J.A. Roberts. 1996. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes & Dev. 10: 1979-1990.
10. Cobrinik, D., P. Whyte, D.S. Peeper, T. Jacks, and R.A. Weinberg. 1993. Cell cycle-specific association of E2F with the p 130 E1A-binding protein. Genes & Dev. 7: 2392-2404.
11. Degregori, J., T. Kowalik, and J.R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15: 4215-4224.
12. Deshaies, R.J., V. Chau, and M.W. Kirschner. 1995. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J. 14: 303-312.
13. Dowdy, F.D., P.W. Hinds, K. Louie, S.I. Reed, and R.A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with Human D cyclins. Cell 73: 499-511.
14. Dynlacht, B.D., O. Flores, J.A. Lees, and E. Harlow. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes & Dev. 8: 1772-1786.
15. Ewen, M.E., H.K. Sluss, C.J. Sherr, H. Matsushime, J. Kato, and D.M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497.
16. Farnham, P.J., J.E. Slansky, and R. Kollmar. 1993. The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta 1155: 125-131.
17. Ginsberg, D., G. Vairo, T. Chittenden, Z.-X. Xiao, G. Xu, K.L. Wydner, J.A. DeCaprio, J.B. Lawrence, and D.M. Livingston. 1994. E2F-4, a new E2F transcription factor family member, interacts with p107 and has transforming potential. Genes & Dev. 8: 2665-2679.
18. Glotzer, M., A.W. Murray, and M.W. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349: 132-138.
19. Goebl, M.G., L. Goetsch, and B. Byers. 1994. The Ubc3 (Cdc34) ubiquitin-conjugating enzyme is ubiquitinated and phosphorylated in vivo. Mol. Cell. Biol. 14: 3022-3029.
20. Haas, A.L. and I.A. Rose. 1982. The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis. J. Biol. Chem. 257: 10329-10337.
21. Hateboer, G., E.M. Hijmans, J.B.D. Nooij, S. Schlenker, S. Jentsch, and R. Bernards. 1996. mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect, J. Biol. Chem. 271: 25906-25911.
22. Helin, K., J.A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 337-350.
23. Hiebert, S.W., M. Lipp, zJ.R. Nevins. 1989. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. 86: 3594-3598.
24. Hijmans, E.M., P.M. Voorhoeve, R.L. Beijersbergen, L.J. van 't Veer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p 130 in vivo. Mol. Cell. Biol. 15: 3082-3089.
25. Hilt, W. and D.H. Wolf. 1996. Proteasomes: Destruction as a programme. Trends Biochem. Sci. 21: 96-102.
26. Hinds, P.W., S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006.
27. Hochstrasser, M. 1995. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7: 215-223.
28. Hofmann, F., F. Martelli, D.M. Livingston, and Z. Wang. 1996. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes & Dev. (this issue).
29. Jentsch, S. 1992. The ubiquitin-conjugation system. Annu. Rev. Genet. 26: 179-207.
30. Jentsch, S. and S. Schlenker. 1995. Selective protein degradation: A journey's end within the proteasome. Cell 82: 881-884.
31. Johnson, D.G., W.D. Cress, L. Jakoi, and J.R. Nevins. 1994a. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. 91: 12823-12827.
32. Johnson, D.G., K. Ohtani, and J.R. Nevins. 1994b. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes & Dev. 8: 1514-1525.
33. Kaelin, W.G., W. Krek, W.R. Sellers, J.A. DeCaprio, F. Ajchenbaum, C.S. Fuchs, T. Chittenden, Y. Li, P. Farnham, M.A. Blanar, D.M. Livingston, and E.K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351-364.
34. Krek, W., M.E. Ewen, S. Shirodkar, Z. Arany, W.G. Kaelin Jr., and D.M. Livingston. 1994. Negative regulation of the growth promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161-172.
35. Krek, W., G. Xu, and D.M. Livingston. 1995. cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83: 1149-1158.
36. Lam, E.W. and R.J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12: 2705-2713.
37. Lees, E., B. Faha, V. Dulic, S.I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p 107 and E2F in a temporally distinct manner. Genes & Dev. 6: 1874-1885.
38. Neuman, E., E.K. Flemington, W.R. Sellers, and W.J. Kaelin. 1994. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell Biol. 14: 6607-6615.
39. Oswald, F., H. Lovec, T. Moroy, and M. Lipp. 1994. E2F-depen- dent regulation of human MYC: Trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene 9: 2029-2036.
40. Pagano, M., S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P.R. Yew, G.F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685.
41. Pickart, C.M. and I.A. Rose. 1985. Functional heterogeneity of ubiquitin carrier proteins. J. Biol. Chem. 260: 1573-1581.
42. Polyak, K., M.H. Lee, B.H. Erdjument, A. Koff, J.M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
43. Qin, X.Q., D.M. Livingston, W.J. Kaelin, and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
44. Rock, K.L., C. Gramm, K. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-777.
45. Rubin, D.M. and D. Finley. 1995. Proteolysis. The proteasome: A protein-degrading organelle? Curr. Biol. 5: 854-858.
46. Sardet, C., M. Vidai, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R.A. Weinberg. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. 92: 2403-2407.
47. Scheffner, M., J.M. Huibregtse, R.D. Vierstra, and P.M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505.
48. Schwob, E., T. Bohm, M.D. Mendenhall, and K. Nasmyth. 1994. The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae. Cell 79: 233-244.
49. Seufert, W., B. Futcher, and S. Jentsch. 1995. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373: 78-81.
50. Shirodkar, S., M. Ewen, J.A. DeCaprio, J. Morgan, D.M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157-166.
51. Singh, P., S.H. Wong, and W. Hong. 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13: 3329-3338.
52. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
53. Treier, M., L.M. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787-798.
54. Vairo, G., D.M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p 130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes & Dev. 9: 869-881.
55. Weintraub, S.J., C.A. Prater, and D.C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259-261.
56. Weintraub, S.J., K.N.B. Chow, R.X. Luo, S.H. Zhang, S. He, and D.C. Dean. 1995. Mechanisms of active transcriptional repression by the retinoblastoma protein. Nature 375: 812-815.
57. Whyte, P., K.J. Buchkovich, J.M. Horowitz, S.F. Friend, M. Ray buck, R.A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334: 124-129.
58. Wiertz, E.J.H.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L. Ploegh. 1996. The human cytotnegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779.
59. Wu, X. and A.J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. 91: 3602-3606.
60. Yaglom, J., M.H. Linskens, S. Sadis, D.M. Rubin, B. Futcher, and D. Finley. 1995. p34Cdc28-mediated control of Cln3 cyclin degradation. Mol. Cell. Biol. 15: 731-741.
61. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p 107, a relative of the retinoblastoma protein. Genes & Dev. 7: 1111-1125.
62. Zhu, L., G. Enders, J.A. Lees, R.L. Beijersbergen, R. Bernards, and E. Harlow. 1995a. The pRB-related protein p 107 contains two growth suppression domains: Independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14: 1904-1913.
63. Zhu, L., L. Zhu, E. Xie, and L.-S. Chang. 1995b. Differential roles of two tandem E2F sites in the repression of the human p 107 promotor by retinoblastoma and p 107 proteins. Mol. Cell. Biol. 15: 3552-3562.